Background. Bacterial meningitis remains a major cause of morbidity and mortality in young infants. Understanding the epidemiology and burden of disease is important.
. Although in the United Kingdom the case fatality associated with neonatal meningitis declined from 25% to 10% between the 1980s and 1990s [4, 5] , long-term sequelae rates did not change, with up to 50% of survivors having long-term neurodevelopmental complications [3, 8] . In France, during 2001-2007, the case fatality for neonatal bacterial meningitis was 13%, but much higher in preterm infants (25%) [9] , and in a recent US study on GBS meningitis, 44% of infants were shown to have long-term morbidity [10] .
Since the late 1990s, a number of initiatives have been introduced in the United Kingdom aimed at improving the care of young infants and reducing the incidence of serious bacterial infections. These include national guidelines for preventing early-onset GBS disease [11] , the introduction of highly effective conjugate vaccines [12, 13] , and improvements in local and specialist neonatal networks and transport systems.
In view of these changes, we undertook an enhanced, prospective, population-based surveillance study in the United Kingdom and the Republic of Ireland to determine the incidence, etiology, and outcome of bacterial meningitis in young infants.
METHODS

Surveillance Protocol
Enhanced national surveillance of bacterial meningitis in infants aged <90 days was undertaken between July 2010 and July 2011 through the British Paediatric Surveillance Unit (BPSU) [14] , hospital microbiology laboratory reports, and parental reporting via meningitis support charities (available at: http://www.neonin.com/neomen-1/bpsu). Pediatricians were asked to report all cases with a clinical diagnosis of bacterial meningitis using the "Orange Card" system, which is sent on a monthly basis to all UK and Irish pediatricians [14] . Infants with an intraventricular shunt device or neural tube defects were excluded. Laboratory-confirmed cases in the target age group were identified by monthly interrogation of LabBase2, a national surveillance database used by National Health Service (NHS) hospital laboratories in England and Wales to voluntarily report clinically significant infections electronically to Public Health England (PHE) [15] . At the same time, PHE Reference Laboratory databases were interrogated for bacterial isolates from meningitis cases in the target age group that had been submitted for identification or typing. In addition, cases were ascertained from Health Protection Scotland and the Irish Meningococcal and Meningitis Reference Laboratory via the Electronic Communication of Surveillance in Scotland and the Computerised Infectious Disease Reporting systems, respectively [16, 17] . Finally, the study was advertised on the websites of and through communications from the UK meningitis and GBS support charities, and parents of infants with bacterial meningitis could report cases by direct contact with these charities (Meningitis Research Foundation, Meningitis UK, Meningitis Trust, and Group B Strep Support).
For all identified cases, the treating clinician was sent a standard questionnaire requesting information on demographics, clinical characteristics, and outcome. Cases ascertained from non-BPSU sources ( parents or laboratory surveillance) were cross-checked with the BPSU reports and then confirmed with the local pediatrician before the questionnaire was sent. To assess completeness of ascertainment for fatal cases in England and Wales, anonymized death registration data provided to PHE by the Office for National Statistics (ONS) for public health surveillance purposes were queried for deaths <90 days of age with "meningitis" recorded on the death certificate.
Data Analysis
Data were entered into a Microsoft Access database and analyzed using Stata version 12.0 (StataCorp, College Station, Texas). An analytical case definition was used to classify confirmed, probable, and possible cases using strict criteria (Figure 1) . The cerebrospinal fluid (CSF) white cell count cutoffs used were based on large studies [18, 19] , with no adjustment for traumatic lumbar puncture [20] . Cases were further classified as early-onset (age 0-6 days) or late-onset (7-89 days), and term (≥37 weeks) or preterm (<37 weeks) at birth. Incidence was calculated using live births in 2010 (after adjustment for the 13-month surveillance period). Live birth data were obtained from ONS [21] , National Records of Scotland (available at: http://www.nrscotland.gov.uk), Northern Ireland Statistics and Research Agency (available at: http://www.nisra.gov.uk), and the Republic of Ireland Central Statistics Office [22] . Because of limited denominator data, incidence by birth weight was calculated for England and Wales only using ONS data [21] , and by gestation for England only using NHS Hospital Episode Statistics data (available for 93% of all live births during 2010-2011) [23] . Neonatal cases (defined as ≤28 days of age) in England and Wales were analyzed separately to allow comparison with previous national studies [4, 5] . Overall, 7-day and 28-day case-fatality ratios (CFRs) from the date of diagnosis were calculated.
Continuous data that did not follow a normal distribution were described as medians with interquartile ranges (IQRs) and compared using the Mann-Whitney U test. Proportions were compared using χ 2 or Fisher exact test, as appropriate.
The binomial method was used to calculate 95% confidence intervals (CIs) for incidence; incidence rate ratios (IRRs) with 95% CIs were used to compare rates.
Ethical Approval
Ethical approval was granted by the Cambridgeshire 2 Research Ethics Committee (reference 10/H0308/45), and permission was also granted to collect patient identifiable information by the National Information Governance Board (reference S251 Support PIAG 6-06(FT1)/2008). PHE has legal permission to collect data for infectious disease surveillance in England and Wales. This principle applies to the laboratory surveillance in the other participating countries.
RESULTS
During the 13-month study period, 868 reports were received, 364 of which (42%) met the analytical case definitions (Figure 1) . The annual incidence of bacterial meningitis in infants aged <90 days was 0.38 (95% CI, .34-.42 ) per 1000 live births, with no significant difference by country (Table 1 ). Overall, rates for confirmed cases only and for confirmed plus possible cases (ie, all cases in which a bacterial pathogen was identified) were 0.30 (n = 282; 95% CI, .26-.33) and 0.31 (n = 298; 95% CI, .28-.35) per 1000 live births, respectively. The median age at presentation was 17 days (IQR, 4-41 days); 113 infants (31%) presented at 0-6 days, 123 (34%) at 7-28 days, and 128 (35%) at 29-89 days. Just more than half (n = 202 [55%]) were male. The incidence of late-onset disease (0.26/1000 live births [95% CI, .23-.30]) was significantly higher than that of early-onset disease (0.12/1000 live births [95% CI, .10-.14]; IRR, 2.2 [95% CI, 1.8-2.8]; P < .0001).
Of the 323 infants with reported ethnicity, 270 (82%) were white, 38 (12%) Asian, and 15 (5%) African, similar to the proportions of 79%, 11%, and 5%, respectively, for all live births in England and Wales [21] .
The incidence was significantly higher in infants with low gestational age and low birth weight (Table 1) , although the median age at presentation was similar for term and preterm infants (14 [IQR, 2-37] vs 15 [IQR, 4-35] days; P = .70).
Etiology
Of the 364 cases, the responsible pathogen was identified in 82% (298 cases; 302 bacteria), including 282 "confirmed" and 16 "possible" cases ( Figure 1 ). A single bacterial species was identified in 99% (n = 295) of culture-confirmed cases. The pathogens were isolated from the CSF alone in 95 (26%), blood alone in 81 (22%), and both in 122 (34%). In an additional 66 cases (18%) ("probable" cases), a pathogen was not identified (Figure 1 Table 2 ).
Among infants presenting from home with late-onset meningitis, GBS was responsible for a significantly higher proportion in premature infants than in term infants (16/20 [80%] vs Two hundred seventy-five (88%) of the cases from England and Wales had birth weight recorded. The remaining cases were distributed to the different weight categories based on proportions from the known cases. The 13-month adjusted number of LBs for birth weight categories was calculated using England + Wales data for 2010 (99% of LBs had birth-weight recorded). Similarly, 278 (93%) of the cases from England had gestation recorded; the remaining cases were distributed to the gestation categories based on the proportions from the known cases. The 13-month adjusted number of LBs by gestation (for England only) was calculated using the available HES data for 2010-2011 and applying the percentages of each category to the total LBs for 2010. In the calculation of the 95% CIs, the uncertainties of the missing categories were neglected.
Abbreviations: CI, confidence interval; HES, Hospital Episode Statistics; IRR, incidence rate ratio; LBs, live births.
* Reference for individual countries.
** Reference for regions of England. (14) 4 (10) 11 (12) 17 (7) OGN 1 (4) 8 (6) 9 (5) 8 (15) 1 (3) 9 (10) 18 ( Table 2 ). The etiology was varied, with GBS and E. coli responsible for approximately one-third of cases each, followed by a range of other Gram-positive and Gram-negative pathogens.
Outcome data were available for 329 cases. The 7-day, 28-day, and overall CFRs were 5.8% (95% CI, 3.5%-8.9%; 19/329), 7.3% (95% CI, 4.7%-10.7%; 24/329), and 7.6% (95% CI, 5.0%-11.0%; 25/329), respectively. Most infants who died did so within a week of their diagnosis (median, 4 [IQR, [1] [2] [3] [4] [5] [6] [7] days). In England and Wales, there were 23 deaths, equal to the number of deaths documented as "meningitis" in the ONS death registration records. CFR was not associated with sex, age at presentation, or route of admission but was significantly higher in preterm infants (15/90 [17%] vs 10/235 [4%] for term infants; P = .0002) as well as in low-birth-weight infants (15/84 [18%] vs 10/220 [5%] for ≥2500-g babies; P = .0002). CFR was also higher for pneumococcal meningitis (5/26 [19%] ) compared with other pathogens (Table 3) .
Neonatal Meningitis Cases (England and Wales)
In England and Wales, the incidence of confirmed and possible neonatal cases (ie, all cases in which a bacterial pathogen was identified) and of all neonatal bacterial meningitis was 0.21 (95% CI, .18-.25; n = 167) and 0.27 (95% CI, .23-.30; n = 208) per 1000 live births, respectively. Half the cases (102/204 [50%]) were admitted from home. A total of 170 bacteria were isolated from 167 cases. GBS (n = 98 [57.6%]), E. coli (n = 25 [14.7%]), S. pneumoniae (n = 10 [5.9%]), and L. monocytogenes (n = 5 [2.9%]) were the main pathogens. The overall CFR was 9.3% (95% CI, 5.7%-14.2%; 19/204), the 28-day CFR was 8.8% (95% CI, 5.3%-13.6%; 18/204), and the CFR for culture-confirmed cases was 11.0% (95% CI, 6.7%-16.9%; 18/163).
DISCUSSION
Our study defines the current incidence of bacterial meningitis in infants aged <90 days in the UK and Republic of Ireland. Previous UK studies have reported rates for neonatal meningitis cases only and/or have not included cases in Scotland, thereby restricting comparison with our study. Analysis of proven bacterial meningitis in neonates in England and Wales, however, indicates that the incidence of disease in this age group has not changed over the last 25 years. The overall CFR was approximately 8% but, for cases of proven neonatal bacterial meningitis in England and Wales, it was 11%, also unchanged from the study performed in 1996-1997 [5] . Comparison with other industrialized countries is difficult because of a lack of published population-based studies. In the United States, a study involving five states during 1986 estimated the incidence of bacterial meningitis in the first 30 days of life to be 0.31 per 1000 live births [24] , a rate similar to our own.
The most common pathogens causing bacterial meningitis in this age group have changed relatively little over the last three decades, with two pathogens (GBS and E. coli) accounting for 63% (n = 191). In studies from other countries, GBS and E. coli have also been identified as the main pathogens causing meningitis in this age group [2, 9, 25] . The dominance of GBS as the leading cause of bacterial meningitis in this age group is clear. In our cohort, the GBS meningitis incidence is unchanged from UK rates from a decade ago [26] , suggesting little impact of the national GBS prevention policy introduced in 2003 [11] . Intrapartum antibiotics can prevent only early-onset GBS infection [27, 28] , and in our study 35% (n = 52) of GBS meningitis occurred in the first week of life, similar to that reported in our previous 2000-2001 study (33% [n = 40]) [26] . It is clear that a better strategy for preventing GBS infection is required.
The pathogens varied by route of admission, gestational age, and age at infection. For example, although GBS was the most common cause of bacterial meningitis overall, its contribution was substantially lower among hospitalized preterm infants, where other pathogens, particularly E. coli, prevailed. Although only 28% of cases were preterm, their risk of meningitis was >4-fold higher than that of term infants. Their case-fatality rate was also significantly higher. Strategies for the prevention and optimal management of meningitis in hospitalized infants must, therefore, be a priority.
Streptococcus pneumoniae contributed to a significant proportion of early onset and late onset meningitis cases, mainly among infants presenting from home. The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) in September 2006, and national follow-up of infants with invasive pneumococcal disease (IPD) during 1998-2010 showed a significant reduction in cases due to PCV7 serotypes but an increase in cases caused by non-PCV7 serotypes [13] . In our cohort, none of the 22 isolates with known serotypes were due to PCV7 serotypes (Table 2) , whereas 18 (82%) were caused by the additional serotypes in the 13-valent pneumococcal conjugate vaccine (PCV13). Replacement of PCV7 with PCV13 in the national immunization schedule in April 2010 has already resulted in significant reductions in IPD caused by these additional serotypes [29] , and so we may anticipate that a similar decline will occur in young infants through indirect protection.
The overall case-fatality rate appears to be unchanged since the mid-1990s [5] , and our neonatal case-fatality rate (11%) is comparable to that reported in a French study (13%) [9] . It is reassuring to note a significantly lower CFR for GBS meningitis (5%) than that reported in the previous study (12%; P = .04) [26] . However, the high CFR for pneumococcal meningitis (19%) is concerning. The incidence and outcome of all meningitis in this age group requires ongoing monitoring
STRENGTH AND LIMITATIONS
As with any national surveillance study, our estimates are likely to represent a minimum incidence because of our strict case definitions and possible underreporting. The BPSU Orange Card return rate over the surveillance period, however, was high (93% from 3200 respondents) [30] . We also maximized ascertainment by using multiple independent sources. On the other hand, the inclusion of probable cases with negative bacterial cultures may have resulted in inclusion of viral meningitis cases and, therefore, overestimated bacterial meningitis cases. These cases, however, were diagnosed by the attending pediatrician as bacterial meningitis on the basis of their clinical presentation with neurological features and CSF pleocytosis. Additionally, in nearly all cases, the lumbar puncture was performed after initiating intravenous antibiotics ( potentially rendering the CSF culture negative), and all cases were then treated with at least 7 days of intravenous antibiotics. Also, culturenegative CSF samples with pleocytosis are generally tested for viruses by NHS hospitals, so a diagnosis of viral meningitis should have been made. Similarly, the inclusion of possible cases was based on the attending pediatrician making a clinical diagnosis in an infant who was generally too unwell to have a lumbar puncture but had neurological features consistent with bacterial meningitis and a significant pathogen cultured from blood. We propose that the inclusion of these probable and possible cases is clinically important and better reflects the true burden of meningitis that pediatricians must deal with.
Notes
